ROSETTA INPHARMATICS INC
10-Q, EX-27.1, 2000-09-13
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: ROSETTA INPHARMATICS INC, 10-Q, 2000-09-13
Next: CAREINSITE INC, 15-12G, 2000-09-13



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM UNAUDITED
FINANCIAL STATEMENTS AS OF JUNE 30, 2000 AND FOR THE SIX MONTHS THEN ENDED.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          27,101
<SECURITIES>                                    21,221
<RECEIVABLES>                                      847
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                51,740
<PP&E>                                           7,589
<DEPRECIATION>                                   2,125
<TOTAL-ASSETS>                                  74,979
<CURRENT-LIABILITIES>                            6,727
<BONDS>                                            818
                                0
                                     82,738
<COMMON>                                             7
<OTHER-SE>                                    (19,350)
<TOTAL-LIABILITY-AND-EQUITY>                    74,979
<SALES>                                              0
<TOTAL-REVENUES>                                 1,919
<CGS>                                                0
<TOTAL-COSTS>                                   20,575
<OTHER-EXPENSES>                                    26
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 135
<INCOME-PRETAX>                               (17,583)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (17,583)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (17,583)
<EPS-BASIC>                                       4.15
<EPS-DILUTED>                                     4.15


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission